Why Is Iovance Therapeutics (IOVA) Stock Down 45% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Iovance Therapeutics (IOVA) stock is falling hard on Friday following the release of clinical trial data for its melanoma treatment. The post Why Is Iovance Therapeutics (IOVA) Stock Down 45% Today? appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”